Barinthus Biotherapeutics (BRNS) Receivables - Net (2020 - 2023)
Barinthus Biotherapeutics (BRNS) reported Receivables - Net of $172000.0 for Q1 2023, down 99.05% on a YoY basis from $18.0 million in Q1 2022, and down 96.89% quarter-over-quarter from $5.5 million in Q4 2022.
Barinthus Biotherapeutics (BRNS) Receivables - Net (2020 - 2023) Analysis & Trends
Barinthus Biotherapeutics has reported Receivables - Net for 4 years, with the latest figure at $172000.0 in Q1 2023.
- For the quarter ending Q1 2023, Receivables - Net fell 99.05% year-over-year to $172000.0; the trailing twelve-month figure through Mar 2023 stood at $172000.0 (down 99.05% YoY), and the FY2022 full-year result was $5.5 million, up 27520.0% from the prior year.
- Receivables - Net for Q1 2023 stood at $172000.0, down from $5.5 million in the prior quarter.
- The five-year high for Receivables - Net was $18.0 million in Q1 2022, with the low at $20000.0 in Q4 2021.
- Historically, Receivables - Net has averaged $2.7 million across 4 years, with a median of $172000.0 in 2023.
- Annual changes were most pronounced in 2022 — Receivables - Net surged 27520.0% — and 2023, when it plunged 99.05%.
- Barinthus Biotherapeutics' Receivables - Net stood at $518000.0 in 2020, then sank by 96.14% to $20000.0 in 2021, then surged by 27520.0% to $5.5 million in 2022, then tumbled by 96.89% to $172000.0 in 2023.
- The last three Receivables - Net figures came in at $172000.0 (Q1 2023), $5.5 million (Q4 2022), and $26000.0 (Q3 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 172,000.00 |
| Mar 31, 2023 | 172,000.00 |
| Dec 31, 2022 | 5.52 Mn |
| Dec 31, 2022 | 5.52 Mn |
| Sep 30, 2022 | 26,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Mar 31, 2022 | 18.01 Mn |
| Mar 31, 2022 | 18.01 Mn |
| Dec 31, 2021 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Sep 30, 2021 | 42,000.00 |
| Sep 30, 2021 | 42,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | 312,000.00 |
| Mar 31, 2021 | 312,000.00 |
| Dec 31, 2020 | 518,000.00 |
| Dec 31, 2020 | 518,000.00 |